These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 27537998)
1. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution. Bristow I; Baran R; Score M J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998 [TBL] [Abstract][Full Text] [Related]
2. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis. Bhatt V; Pillai R J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933 [TBL] [Abstract][Full Text] [Related]
3. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution. Cantrell W; Canavan T; Elewski B J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674 [TBL] [Abstract][Full Text] [Related]
4. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Zaias N; Rebell G Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459 [TBL] [Abstract][Full Text] [Related]
5. Tavaborole 5% Topical Solution for the Treatment of Toenail Onychomycosis in Pediatric Patients: Results from a Phase 4 Open-Label Study. Rich P; Spellman M; Purohit V; Zang C; Crook TJ J Drugs Dermatol; 2019 Feb; 18(2):190-195. PubMed ID: 30811142 [TBL] [Abstract][Full Text] [Related]
6. Trichophytum rubrum endonyx onychomycosis resistant to standard oral and topical therapies. Mulvaney PM; Telang GH; Jellinek N Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437286 [TBL] [Abstract][Full Text] [Related]
7. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis. Scher RK; Nakamura N; Tavakkol A Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346 [TBL] [Abstract][Full Text] [Related]
8. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space. Elewski BE; Pollak RA; Pillai R; Olin JT J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708 [TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study. Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055 [TBL] [Abstract][Full Text] [Related]
10. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis? Elewski BE; Cantrell W; Lin T J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225 [TBL] [Abstract][Full Text] [Related]
11. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK; Gover MD; Lynde CW J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [TBL] [Abstract][Full Text] [Related]
12. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.). Shemer A; Gupta AK; Amichai B; Farhi R; Baran R; Daniel CR; Daigle D; Foley KA J Dermatolog Treat; 2016 Oct; 27(5):480-3. PubMed ID: 27032812 [TBL] [Abstract][Full Text] [Related]
13. Tavaborole topical solution (Kerydin) for onychomycosis. Med Lett Drugs Ther; 2015 Mar; 57(1463):35-6. PubMed ID: 25719999 [No Abstract] [Full Text] [Related]
14. Onychomycosis: An Updated Review. Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146 [TBL] [Abstract][Full Text] [Related]
15. Topical Tavaborole in the Treatment of Onychomycosis Complicated by Dermatophytoma: A Post-hoc Assessment of Phase II Subjects. Aly R; Winter T; Hall S; Vlahovic T J Drugs Dermatol; 2018 Mar; 17(3):347-354. PubMed ID: 29537453 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329 [TBL] [Abstract][Full Text] [Related]
17. Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Amichai B; Nitzan B; Mosckovitz R; Shemer A Br J Dermatol; 2010 Jan; 162(1):46-50. PubMed ID: 19785609 [TBL] [Abstract][Full Text] [Related]
18. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails. Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707 [TBL] [Abstract][Full Text] [Related]
19. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
20. Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection. Pariser DM; Wendelken ME; Rycerz AM; Gellings Lowe N; Yost JM; Lipner SR J Drugs Dermatol; 2018 Feb; 17(2):168-172. PubMed ID: 29462224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]